June 21, 2016
First SU2C Catalyst RFP Announced with support from Merck
Stand Up To Cancer (SU2C) announced today the first Request For Proposals (RFP) under SU2C Catalyst™, a program working with industry to support clinical trials and translational research. Funded by SU2C Catalyst Founding Collaborator Merck, known as MSD outside the United States and Canada, the grants will support investigation of new uses of the company’s anti-PD-1 therapy, Keytruda® (pembrolizumab), alone or in combination with other agents from Merck or other companies.
Read MoreJune 16, 2016
Stand Up To Cancer Returns For Fifth Live Roadblock Telecast
The Hollywood community is once again uniting to support Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), which will stage its fifth biennial televised fundraising special on Friday, Sept. 9 (8:00 – 9:00 PM ET/PT / 7:00 PM CT). Academy Award-nominated actor and founder of the Charles J Cooper Patient Support Fund, Bradley Cooper, will serve as executive producer along with renowned live, large-scale event producers Done + Dusted, working with Stand Up To Cancer’s production team. Additional stars and performers will be announced in the coming w
Read MoreMay 9, 2016
SU2C to Offer Training Modules for Nurses on Front Lines of Administering New Cancer Therapies
In recognition of Nurses Appreciation Week, Stand Up To Cancer (SU2C) announces the development of a series of Certification for Nursing Education (CNE) training modules by experts from Boston College William F. Connell School of Nursing. The CNE modules will equip nurses with the skills and knowledge needed to manage the unique challenges and patient symptoms that accompany administration of emerging immunotherapies to treat cancer. The first of a series of the three web-based SU2C-Boston College Immunotherapy CNE modules will be available to nurses in July 2016.
Read MoreMay 5, 2016
Minnie Driver Joins SU2C, OCRFA and NOCC in New PSA
Stand Up To Cancer (SU2C), Ovarian Cancer Research Fund Alliance (OCRFA), and National Ovarian Cancer Coalition (NOCC) have teamed up on a new ovarian cancer public service announcement (PSA) campaign featuring Academy-Award nominated actress Minnie Driver, who lost her grandmother to the disease. The print, radio, out-of-home, and digital PSAs will begin running in May.
Read MoreMay 4, 2016
Stand Up To Cancer and Genentech Join Forces through “Be the Breakthrough” Campaign
Stand Up To Cancer (SU2C) and Genentech announced their latest collaboration “Be the Breakthrough”, a multi-faceted campaign focused on educating Americans on how they can each play a role in the fight against cancer, including screening and participating in clinical trials.
Read MoreMay 2, 2016
SU2C Supports “Innovation in Collaboration” with $1M for Five Teams Through Philip A. Sharp Awards
Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-affiliated scientists. Each team, consisting of researchers from different SU2C-supported “Dream Teams” or research programs, will receive a grant of $200,000 to support new research projects stemming from previous advances in cancer research from the SU2C community. Four of the five teams are focused on immunotherapy and the fifth on DNA repair.
Read MoreApril 18, 2016
Stand Up To Cancer Supports Innovative Research Grants for 10 Early-career Scientists
Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer Research, SU2C’s Scientific Partner.
Read MoreApril 13, 2016
Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry
Stand Up To Cancer (SU2C), the charitable initiative aimed at bringing new treatments to cancer patients quickly, today announced Catalyst, a new program that will use funding and materials from the pharmaceutical, biotechnology, diagnostic and medical devices industries to accelerate research on cancer prevention, detection and treatment. Founding collaborator Merck; and Bristol-Myers Squibb Company, and Genentech, a member of the Roche Group, are Charter Supporters.
Read MoreApril 11, 2016
SU2C Honors Katie Couric For Her Dedication to Cancer Advocacy at NYC Star-Studded Fundraising Event
Stand Up To Cancer (SU2C) honored SU2C Co-Founder and award-winning journalist Katie Couric for her dedication to cancer advocacy at a star-studded fundraising event here Saturday night. A portion of the proceeds will be devoted to research on colorectal cancer, the disease that took her first husband’s life and launched her tireless career as a cancer advocate.
Read MoreFebruary 18, 2016
Greg Kinnear Joins Stand Up To Cancer and Lilly Oncology in New Colorectal Cancer PSA
Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), has teamed up with Eli Lilly and Company on a new colorectal cancer public service announcement (PSA) featuring actor and SU2C Ambassador Greg Kinnear. The PSA will begin airing in March during National Colorectal Cancer Awareness Month.
Read More